← Mechanisms of action
Adrenergic receptor
PROTEIN FAMILYHomo sapiens
Linked proteins
- Alpha-1A adrenergic receptor (ADRA1A) ↗
- Alpha-2A adrenergic receptor (ADRA2A) ↗
- Beta-1 adrenergic receptor (ADRB1) ↗
- Beta-2 adrenergic receptor (ADRB2) ↗
- Alpha-2C adrenergic receptor (ADRA2C) ↗
- Alpha-1D adrenergic receptor (ADRA1D) ↗
- Alpha-1B adrenergic receptor (ADRA1B) ↗
- Alpha-2B adrenergic receptor (ADRA2B) ↗
- Beta-3 adrenergic receptor (ADRB3) ↗
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| dipivefrin (propine) | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| droxidopa (northera) | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| ephedrine | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| hydroxyamphetamine (paredrine) | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| mephentermine sulfate (wyamine sulfate) | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| norepinephrine (levophed) | Agonist | approved | Small molecule | Adrenergic receptor agonist |
| labetalol (trandate) | Antagonist | approved | Small molecule | Adrenergic receptor antagonist |
| eg017 | Modulator | experimental | Small molecule | Adrenergic receptor modulator |